Quorex and IDEC Pharmaceuticals Ink Collaboration

Sep 03, 2003

NEW YORK, Sept. 3 (GenomeWeb News) - Quorex Pharmaceuticals of Carlsbad, Calif., and IDEC Pharmaceuticals of San Diego today announced a research collaboration seeking novel genes encoding proteins for use as therapeutic targets for cancers and inflammatory disorders.

Quorex will apply its Protein Vision bioinformatics tools -- which include genome annotation, homology modeling, and protein-fold prediction tools -- and receive undisclosed up-front and research payments.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Breaking News

The Scan

To Control the Spread

An Australian-led team has generated a draft genome assembly of the invasive cane toad in hopes it will help in population control, the Sydney Morning Herald reports.

More to Do

The New York Times reports that the US Department of Defense has implemented about half the recommendations made to improve safe handling of dangerous agents.

This Week in PLOS

In PLOS this week: approach for teasing out archaic introgression in human genomes, immune transcription features in HCV infection, and more.

'Follow Me to Maryland'

Stat News reports that Maryland is promoting itself to the biotech industry with a mobile billboard.

Main menu